SAN FRANCISCO and SUZHOU,China, April 23, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic,...
Read More Details
Finally We wish PressBee provided you with enough information of ( Seven Oral Presentations: Innovent to Present Breakthrough Clinical Data of IBI363（PD-1/IL-2α-bias）and Other Novel Drug Candidates at the 2025 ASCO Annual Meeting )
Also on site :
- Popular Chip Brand's Summertime Exclusive Flavor Is Too 'Interesting' Not to Try
- No Way: FBI Assesses That Venezuela Facilitating Migration of Gang Members to US
- Shannon Sharpe accused of choking female production assistant at Fox Sports prior to $50M rape lawsuit: report